Dietary intakes of fat and total mortality among Japanese populations with a low fat intake: the Japan Collaborative Cohort (JACC) Study by Kenji Wakai et al.
Wakai et al. Nutrition & Metabolism 2014, 11:12
http://www.nutritionandmetabolism.com/content/11/1/12RESEARCH Open AccessDietary intakes of fat and total mortality among
Japanese populations with a low fat intake: the
Japan Collaborative Cohort (JACC) Study
Kenji Wakai1*, Mariko Naito1, Chigusa Date2, Hiroyasu Iso3, Akiko Tamakoshi4 for the JACC Study GroupAbstract
Background: It may be useful to examine associations of fat intakes with total mortality as a basis for dietary
recommendations. We aimed to elucidate associations between dietary fat and total mortality among Japanese
populations with low fat intake.
Methods: We conducted a prospective study consisting of 58,672 men and women aged 40 to 79 years. Fat
intakes were estimated using a food frequency questionnaire. Multivariate-adjusted hazard ratios (HRs) for mortality
by sex were computed according to quintiles of energy-adjusted fat intakes.
Results: During the follow-up period (median duration, 19.3 years), 11,656 deaths were recorded. In men, we found
no clear association between total fat and total mortality. HRs across quintiles of total fat intake were 1.00, 1.03
(95% confidence interval [CI], 0.95–1.12), 1.02 (0.94–1.10), 0.98 (0.90–1.07), and 1.07 (0.98–1.17). No significant
association was detected in regard to types of fat. In women, HR was lowest in the fourth quintile of total fat intake
followed by the top quintile; HRs across quintiles were 1.00, 1.03 (0.94–1.11), 1.00 (0.92–1.09), 0.88 (0.81–0.96), and
0.94 (0.86–1.03). Regarding types of fat in women, total mortality was inversely associated with intakes of saturated
fatty acids (SFA), monounsaturated fatty acids (MUFA), and polyunsaturated fatty acids (PUFA); the lowest HR was in
the top quintile of intake for SFA, MUFA, and PUFA: 0.91 (95% CI, 0.83–1.00), 0.91 (0.83–0.99) and 0.88 (0.80 − 0.97),
respectively (trend P across quintiles, 0.020, 0.012, and 0.029, respectively). Causes of death other than cancer and
cardiovascular disease contributed most to decreases in HRs for total and types of fat. In women, analysis with finer
categories revealed that the lowest risk for total mortality appeared at total fat intake of 28% of energy.
Conclusions: Our findings from a large cohort study among populations with relatively low fat intake provide
evidence regarding optimal levels of fat intakes.
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Governmental authorities and institutions in developed
countries have long recommended reductions in the in-
take of dietary fat [1-3]. These recommendations are de-
rived mainly from the associations of higher intakes of fat
and its components with the risk of cardiovascular disease
(CVD), overweight, and cancer, although such associations
have not necessarily been supported in subsequent studies* Correspondence: wakai@med.nagoya-u.ac.jp
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reproduction in any medium, provided the or[1]. In recent years, greater emphasis has been placed on
the reduction of saturated fatty acid (SFA) and trans-fatty
acid intakes rather than total fat [1,3].
In addition to associations with the risk of specific dis-
eases, relationships to total health may be important in
determining optimal lifestyle and medical factors. Total
mortality is one of the most concrete indices for total
health. Many studies have related total mortality to fac-
tors such as alcohol intake [4], sleep [5], and overweight
or leanness [6,7], and have proposed acceptable ranges
of alcohol consumption, sleep duration, and body mass
index (BMI). Examining the associations of fat intaketd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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a useful basis for formulating dietary recommendations.
Nevertheless, studies relating fat intake in adults to
total mortality are scarce. Leosdottir et al. [8] examined
the association of intake of total fat and its components
with all-cause mortality and reported no clear relationship.
Mean intakes of total fat in that study (39.7% and 38.4%
of total energy in men and women, respectively), however,
were higher compared to the range proposed in dietary
guidelines (20-35% of energy) [1-3]. Furthermore, the mean
SFA intake (about 16% of energy) exceeded the upper limit
recommended in guidelines (7–10% of energy) [1-3].
Nagata et al. [9] recently reported that total fat intake
was negatively associated with all-cause mortality in men,
but not in women, in a Japanese population with low fat
consumption (median, 22.7% and 23.7% of total energy in
men and women, respectively). Studies among populations
with relatively low fat intake may thus help elucidate
optimum intake levels in relation to lowest risk of total
mortality. To the best of our knowledge, however, no
other study has examined the association between total fat
intake and all-cause mortality.
We have been conducting a large cohort study, the
Japan Collaborative Cohort (JACC) Study, for the evalu-
ation of cancer risk, sponsored by the Monbu-Kagaku-sho
(Ministry of Education, Culture, Sports, Science and Tech-
nology) of Japan [10-12] since 1988. This study involves
participants throughout Japan, where fat intake is lower
compared with Western countries; in 1990, when the
baseline survey was undertaken, mean fat intake was 25.3%
of total energy [13]. In contrast, total fat intake contrib-
utes an average of 33% of energy for men and women
in the United States (2007–2010) [14], and 33-39% for
men and 33–40% for women in four European countries
(2005–2011) [15-18].
We surmised that if the optimum level of fat intake
with the lowest risk of mortality exists at a level lower
than in Western countries, investigations on the rela-
tionship between fat intake and mortality using popula-
tions with lower fat intake would prove informative. We
therefore examined associations for intakes of total fat
and its components with total and major causes of death
by analyzing data from the JACC Study.
Methods
Study cohort
The baseline survey of the JACC Study was conducted
from 1988 through 1990. In that survey, 110,585 male and
female inhabitants aged 40 to 79 years completed a ques-
tionnaire [10-12]. The JACC Study was a multi-institutional
collaborative study in which 24 research institutions and
hospitals voluntarily participated. Recruitment of study par-
ticipants fell to each investigator, who arbitrary defined the
area and target population. Participants were enrolled from45 study areas throughout Japan: 3 towns in Hokkaido
district; 5 towns in Tohoku district; 5 towns in Kanto
district; 1 city, 3 towns and 2 villages in Chubu district;
8 towns and 2 villages in Kinki district; 1 city and 1
town in Chugoku district; and 4 cities, 9 towns and 1
village in Kyushu district.
In 22 of the 45 study areas, all residents living in a de-
fined target area were regarded as study subjects. In 20
areas, participants in a basic health examination con-
ducted under the Health and Medical Service Law for
the Aged were invited to join the study. In 2 areas, study
subjects comprised health check-up participants plus
volunteers. In 1 area, subjects were recruited from those
who undertook the health examination for atomic bomb
survivors. The response rate was 83%. Informed consent
for participation was obtained individually from each par-
ticipant, except in a few study areas where consent was
obtained at the group level after the aims of the study
and the confidentiality of data had been explained to
community leaders. The ethics boards of Nagoya Uni-
versity School of Medicine and Hokkaido University
Graduate School of Medicine approved the protocol
for this investigation, including the procedures used to
obtain informed consent.
Potential participants for the present analysis were re-
stricted to 86,401 men and women who lived in 34 study
areas where a food frequency questionnaire (FFQ) to esti-
mate food and nutrient intake was included in the baseline
questionnaire. Of the 86,401 potential participants, we ex-
cluded: 4,678 men and women with a history of cancer,
stroke, or myocardial infarction; 22,941 without sufficient
responses to the FFQ to estimate nutrient intake (judged
by predefined criteria); and 110 with implausibly high or
low total energy intakes (<500 or >3,500 kcal/d). As a re-
sult, 23,115 men and 35,557 women were eligible for the
present analysis.
Diet and other exposure data
The baseline questionnaire covered lifestyle factors, in-
cluding dietary habits, smoking and drinking, and phys-
ical activity, as well as medical history, education, and
height and weight.
The dietary component of the questionnaire included
40 food items [19]. For 33 foods or dishes, we asked
about the average intake frequency without specifying
portion size. We used the following 5 response choices:
almost never; 1–2 times a month; 1–2 times a week; 3–4
times a week; and almost every day. For rice, miso soup
(soup of fermented soybean paste with soybean curd,
vegetables, and/or seaweed, etc.), and 4 non-alcoholic
beverages, we asked about the number of bowls or cups
consumed each day. For alcoholic beverages, we in-
quired about the frequency of consumption and the
usual amount on each occasion. Nutrient intakes were
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assuming standard portion sizes. The supplemented ver-
sion of the food composition table was employed for n-3
and n-6 polyunsaturated fatty acids (PUFA). Energy-
adjusted dietary intakes of nutrients, including total fat,
SFA, monounsaturated fatty acids (MUFA), PUFA, and
n-3 and n-6 PUFA, and consumption of vegetables and
fruit, were calculated by the residual method [21]. For
this adjustment for energy, natural logarithms of energy,
nutrient, or dietary intakes were used to improve the
normality of distributions. Energy intake was not ad-
justed when computing the PUFA-to-SFA (P/S) ratio.
The FFQ was validated by referring to four 3-day
weighted dietary records over a 1-year period as a stand-
ard [19]. We reanalyzed data from the validation study
to consider skewed distributions of nutrient intakes and
within-person variation in intakes [22,23]. De-attenuated
correlation coefficients for energy-adjusted intakes be-
tween the FFQ and dietary records were 0.51 for total
fat, 0.56 for SFA, 0.49 for MUFA, and 0.35 for PUFA.
Ratios of median intakes (% of energy [%E]) estimated
by the FFQ to those calculated from the dietary records
were 0.84, 1.12, 0.80, and 0.68 for total fat, SFA, MUFA,
and PUFA, respectively.Follow-up
We used population registries from the involved muni-
cipalities to determine the vital and residential status
of participants. Registration of death is required by the
Family Registration Law in Japan and is adhered to nation-
wide. For logistical reasons, we discontinued the follow-up
of subjects who had moved out of their given study area.
Causes of death were ascertained by means of a systematic
review of death certificates. The underlying cause of death
was coded in accordance with the rules of the 10th
Revision of the International Statistical Classification of
Diseases and Related Health Problems (ICD-10). Cancer
was defined using codes C00-C97, CVD using I00-I99,
coronary heart disease (CHD) using I20-I25, and stroke
using I60-I69.
Follow-up was conducted from the time of the base-
line survey through to the end of 2009, except in 6 areas
(to the end of 1999, 2003, and 2008 for 3, 1, and 2 areas,
respectively). During the study period, 5.8% (n = 3,395)
of participants in the analytic cohort were lost to follow-
up, mostly due to moving away from study areas.Statistical analysis
BMI at baseline was calculated from reported height and
weight. The linear trend of background characteristics
across quintiles of total fat intake was statistically tested
using the linear regression model for continuous vari-
ables and the Mantel-Haenszel χ2 test for categoricalvariables. In these tests for trend, scores of 0, 1, 2, 3, and
4 were assigned to the successive quintiles.
We counted person-time of follow-up for each partici-
pant from the date of filling out the baseline question-
naire to the date of death from any cause, the date of
emigration outside the study area, or the end of the
follow-up period, whichever came first. Subjects who
moved out of their study area were treated as censored
cases. Hazard ratios (HRs) with 95% confidence intervals
(CIs) for total, cancer, cardiovascular, and other mortality
over quintiles of energy-adjusted intakes of total fat, SFA,
MUFA, PUFA, and n-3 and n-6 PUFA, and quintiles of P/
S ratio (HRs for the second to the highest quintiles versus
the lowest) were estimated using proportional hazards
modeling [24] by sex. We also computed HRs among male
never-drinkers to assess confounding or effect modifica-
tions by alcohol consumption, because alcohol accounted
for a considerable proportion of energy intake in men.
HRs were adjusted for age (as a continuous variable), geo-
graphic area (Hokkaido, Tohoku, Kanto, Chubu, Kinki,
Chugoku, or Kyushu), educational level (attended school
until ≤ 15, 16–18, or ≥ 19 years old), smoking (never-
smoker, ex-smoker, or current smoker who smoked < 20,
20–39, or ≥ 40 cigarettes per day), alcohol consumption
(never-drinker, ex-drinker, or current drinker who con-
sumed < 1.0, 1.0–1.9, 2.0–2.9, or ≥ 3.0 Japanese standard
drinks [23 g of ethanol] per day), BMI (< 20.0, 20.0–24.9,
25.0–29.9, or ≥ 30.0 kg/m2), sleep duration (< 6.0, 6.0–6.9,
7.0–7.9, 8.0–8.9, or ≥ 9.0 h per day), daily walking habits
(almost none, about 30, 30–60, or ≥ 60 min per day), con-
sumption of vegetables (quintiles 1–5) and fruit (quintiles
1–5), and total energy intake (as a continuous variable).
We considered walking time because that was the major
physical activity in the study population [25]. Missing
values for each covariate were treated as an additional cat-
egory in the variable and were included in the propor-
tional hazards model. As a basis for the trend tests for
HRs over the quintiles, median energy-adjusted fat intake
in each quintile was included in the model. We repeated
the analyses for total mortality after excluding the first
3 years of follow-up, in which 817 deaths were recorded,
from the risk period.
We also attempted further analysis, dividing each of
the fourth and top quintiles of total fat intake into lower
and upper halves (10% of the cohort) [26] to seek intake
levels associated with the lowest risk of total mortality,
because a lower HR was found in these two quintiles in
women. The reference was set to those with the lowest
quintile of intake. In addition, to explicate roles of mac-
ronutrients replaced by fat, we added energy-adjusted in-
take of protein or carbohydrate (as a continuous variable)
to the multivariate model for total fat intake. The effect of
substituting fat for carbohydrate can be assessed using the
multivariate model with energy-adjusted protein intake,
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model with energy-adjusted intake of carbohydrate [9]. In
these models, energy intake is considered to be kept con-
stant because total energy was also incorporated in the
model [27]. All P values were 2-sided, and all analyses
were performed using Statistical Analysis System version
9.1 software (SAS Institute, Cary, NC).Results
Median intake of total fat (% of energy) was 10.8–23.3%
in men and 13.7–26.8% in women across the quintiles of
energy-adjusted intake (Table 1). Intake of protein in-
creased and that of carbohydrate decreased with increas-
ing level of total fat intake. Men and women with higher
fat intake tended to consume more vegetables and fruit,
to be highly educated, and to have slightly lower BMI,
and were less likely to be current smokers. Age corre-
lated positively with fat intake in men, but showed an in-
verse correlation in women. We found the following
associated with increasing fat intake among men: de-
creasing weight; decreasing trends in proportions of
current drinkers and smokers; and increasing trends in
the proportions of former drinkers and smokers. Among
women, the following were associated with increasing fat
intake: decreasing trend in the proportion walking ≥1 h/
day; and increasing proportion of current drinkers. Al-
though the trend was significant in women, sleep duration
did not materially vary among the fat intake categories.
During a median follow-up of 19.3 years (interquartile
range, 11.4–20.8 years), 11,656 deaths were recorded
among 58,672 participants. The most common cause of
death was cancer (n = 4,241; 36.4%), followed by CVD
(n = 3,393; 29.1%). Among men (Table 2), we found no
clear trend for total mortality across quintiles of fat in-
takes except for increasing trends in HRs with increasing
intakes of PUFA (particularly of n-6 PUFA) and P/S ra-
tio. Excluding the first 3 years of follow-up from the risk
period did not essentially alter the findings (data not
shown). Significant associations were not detected be-
tween fat intakes and total mortality in men in the ana-
lysis limited to never-drinkers (n = 4,454), although a
somewhat reduced risk was seen in the second highest
quintile of total fat intake; HRs across the quintiles were
1.00, 1.00 (95% CI, 0.84–1.19), 1.01 (0.84–1.21), 0.92
(0.76–1.11), and 0.98 (0.81–1.18) (trend P = 0.58; data
not shown for SFA, MUFA, PUFA, n-3 and n-6 PUFA,
and P/S ratio).
With regard to major causes of death, cardiovascular
mortality correlated positively with PUFA (principally
n-6 PUFA) intake. This positive association with n-6
PUFA in men was mostly explained by stroke (data not
shown). A lower risk of CVD deaths was observed in the
lowest quintile of P/S ratio. As for cancer mortality, theHR was significantly elevated in the highest quintile of
total fat intake.
Among women, total mortality was inversely associ-
ated with intakes of total fat, SFA, MUFA, and PUFA
(Table 3). The HR was lowest in the second highest
quintile of intake for total fat (0.88; 95% CI, 0.81–0.96)
followed by the top quintile. This corresponds to a de-
crease of 131 per 100,000 person-years in the absolute
mortality rate in the fourth quintile compared with the
lowest quintile. On the other hand, the lowest HR was
found in the top quintile of intake for SFA, MUFA, and
PUFA. Causes of death other than cancer and CVD con-
tributed most to the decrease in the HR. HRs for total
mortality were not substantially changed by excluding
the first 3 years of follow-up from the risk period (data
not shown).
Analysis further dividing the fourth and top quintiles
of total fat intake into lower and upper halves revealed a
U-shaped association between fat intake and total mor-
tality in women, but not in men (Figure 1). When HRs
were plotted against median intake of total fat (%E) in
each category, the lowest HR appeared at 23% energy
from fat in women.
In analyses with further adjustment for energy-adjusted
intake of protein or carbohydrate, a slightly lower HR for
total mortality tended to be seen in the fourth quintile of
total fat intake among men, but did not reach the level of
statistical significance (P > 0.10). HRs across quintiles were
1.00, 1.01 (95% CI, 0.92–1.11), 0.99 (0.89–1.09), 0.94
(0.84–1.06), and 1.02 (0.89–1.17) in the protein-adjusted
model (trend P = 0.88), and 1.00, 1.02 (95% CI, 0.93–1.11),
0.99 (0.91–1.09), 0.95 (0.86–1.05), and 1.02 (0.90–1.16) in
the carbohydrate-adjusted model (trend P = 0.76). Among
women, the association between total fat intake and all-
cause mortality remained similar even after such adjust-
ment, but was somewhat attenuated after adjustment for
protein. The linear trend was not significant in either the
protein- or carbohydrate-adjusted model. Respective HRs
were 1.00, 1.04 (95% CI, 0.95–1.14), 1.03 (0.92–1.14), 0.91
(0.81–1.02), and 0.98 (0.86–1.12) in the protein-adjusted
model (trend P = 0.32), and 1.00, 1.02 (95% CI, 0.93–1.13),
1.00 (0.89–1.13), 0.88 (0.76–1.02), and 0.94 (0.78–1.14) in
the carbohydrate-adjusted model (trend P = 0.29).
Discussion
In this large, community-based, prospective cohort study,
we found overall inverse associations of total mortality with
intakes of total fat, SFA, MUFA, and PUFA in women, par-
ticularly among those aged ≥ 60 years, but not in men. In
women, detailed analysis revealed a U-shaped association
between total fat intake and total mortality; the lowest risk
appeared within the second highest quintile of energy-
adjusted fat intake. Regarding major causes of death in
men, an upward trend in the HR for CVD mortality was
Table 1 Baseline characteristics of subjects by quintile (Q1–Q5) of total fat intake (adjusted for energy intake): 23,115
men and 35,557 women in the JACC Study, 1988-2009
Quintiles of total fat intake Trend P
Q1 Q2 Q3 Q4 Q5
Men (n = 23,115)
n 4,623 4,623 4,623 4,623 4,623
Age at baseline, y 54.9 ± 9.6 55.0 ± 9.7 55.9 ± 9.8 56.4 ± 10.1 57.7 ± 10.2 <0.001
Total energy intake, kcal/d 1,716 ± 478 1,763 ± 480 1,778 ± 479 1,752 ± 497 1,692 ± 490 0.009
Total fat intake, %E median (IQR) 10.8 (9.4–11.9) 13.9 (13.0–15.0) 16.3 (15.2–17.5) 18.8 (17.6–20.3) 23.3 (21.3–25.8) < 0.001
SFA 3.0 (2.5–3.5) 4.1 (3.5–4.7) 4.9 (4.3–5.6) 5.8 (5.1–6.6) 7.3 (6.4–8.4) < 0.001
MUFA 3.3 (2.8–3.7) 4.3 (4.0–4.7) 5.0 (4.7–5.4) 5.9 (5.4–6.4) 7.4 (6.7–8.3) < 0.001
PUFA 2.6 (2.1–3.1) 3.3 (2.8–3.7) 3.7 (3.3–4.2) 4.2 (3.7–4.6) 5.0 (4.4–5.6) < 0.001
Protein intake, %E median (IQR) 10.2 (9.3–11.1) 11.9 (11.1–12.7) 13.0 (12.2–13.9) 14.2 (13.2–15.2) 16.0 (14.8–17.5) < 0.001
Carbohydrate intake,
%E median (IQR)
64.2 (56.9–72.4) 61.6 (54.4–68.4) 59.4 (52.8–65.7) 58.0 (51.5–62.9) 53.2 (47.5–58.1) < 0.001
BMI, kg/m2 22.8 ± 3.2 22.7 ± 2.8 22.7 ± 2.7 22.7 ± 3.3 22.6 ± 2.8 < 0.001
Weight, kg 60.8 ± 8.8 60.9 ± 8.9 60.7 ± 8.7 60.5 ± 8.6 60.0 ± 8.7 < 0.001
Sleep duration, h/d 7.4 ± 1.1 7.4 ± 1.0 7.4 ± 1.0 7.4 ± 1.0 7.4 ± 1.1 0.93
College or higher education, % 14.4 16.8 17.5 20.7 23.2 < 0.001
Alcohol consumption
Current drinkers, % 81.2 79.1 77.4 72.8 64.7 < 0.001
Former drinkers, % 4.1 3.9 5.0 5.9 9.6 < 0.001
Smoking
Current smokers, % 60.4 55.4 54.0 51.4 49.3 < 0.001
Former smokers, % 22.1 25.4 25.8 25.7 26.0 < 0.001
Vegetable consumption, g/d 80.9 ± 46.6 101.5 ± 50.3 112.0 ± 52.3 123.8 ± 53.5 139.9 ± 57.4 < 0.001
Fruit consumption, g/d 75.0 ± 62.2 94.2 ± 66.0 104.8 ± 68.3 117.0 ± 69.2 128.9 ± 70.8 < 0.001
Walking > = 1 h/d, % 49.4 50.9 50.2 49.5 48.5 0.19
Women (n = 35,557)
n 7,111 7,112 7,111 7,112 7,111
Age at baseline, y 57.5 ± 10.0 56.4 ± 9.9 56.1 ± 9.9 55.7 ± 9.7 55.6 ± 9.8 < 0.001
Total energy intake, kcal/d 1,429 ± 400 1,447 ± 361 1,451 ± 326 1,463 ± 337 1,401 ± 376 0.002
Total fat intake, %E median (IQR) 13.7 (11.9–15.0) 17.6 (16.8–18.3) 20.1 (19.5–20.7) 22.6 (21.9–23.4) 26.8 (25.3–28.9) < 0.001
SFA 3.7 (3.1–4.4) 5.2 (4.6–5.9) 6.3 (5.6–6.8) 7.1 (6.5–7.7) 8.6 (7.7–9.7) < 0.001
MUFA 4.2 (3.6–4.6) 5.4 (5.1–5.7) 6.2 (6.0–6.6) 7.1 (6.8–7.5) 8.6 (8.0–9.3) < 0.001
PUFA 3.2 (2.6–3.8) 4.0 (3.5–4.5) 4.4 (3.9–4.9) 4.8 (4.3–5.3) 5.5 (4.9–6.2) < 0.001
Protein intake, %E median (IQR) 12.3 (11.3–13.3) 14.2 (13.4–15.1) 15.3 (14.4–16.2) 16.3 (15.4–17.3) 17.9 (16.7–19.2) < 0.001
Carbohydrate intake, %E median (IQR) 71.7 (69.7–74.2) 66.6 (65.1–67.9) 63.2 (61.8–64.4) 59.8 (58.3–61.2) 54.3 (51.1–56.6) < 0.001
BMI, kg/m2 23.1 ± 3.3 23.1 ± 4.5 22.9 ± 3.0 22.9 ± 3.0 22.7 ± 3.5 < 0.001
Weight, kg 52.4 ± 8.2 52.7 ± 7.9 52.6 ± 7.7 52.6 ± 7.5 52.4 ± 7.4 0.86
Sleep duration, h/d 7.1 ± 1.1 7.1 ± 1.1 7.1 ± 1.0 7.1 ± 1.0 7.0 ± 1.0 < 0.001
College or higher education, % 7.5 9.1 10.3 11.8 14.8 < 0.001
Alcohol consumption
Current drinkers, % 21.5 23.2 23.1 24.0 25.1 < 0.001
Former drinkers, % 1.7 1.5 1.4 1.3 1.9 0.73
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Table 1 Baseline characteristics of subjects by quintile (Q1–Q5) of total fat intake (adjusted for energy intake): 23,115
men and 35,557 women in the JACC Study, 1988-2009 (Continued)
Smoking
Current smokers, % 6.5 5.2 4.1 4.1 4.5 < 0.001
Former smokers, % 1.7 1.2 1.3 1.3 1.5 0.39
Vegetable consumption, g/d 101.0 ± 50.7 118.5 ± 51.5 127.7 ± 52.4 137.6 ± 53.1 145.3 ± 54.9 < 0.001
Fruit consumption, g/d 112.6 ± 70.2 133.0 ± 68.9 140.7 ± 67.9 147.2 ± 67.2 149.7 ± 67.4 < 0.001
Walking > = 1 h/d, % 53.3 53.4 51.2 51.2 48.6 < 0.001
Plus-minus values are means ± SD.
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cer mortality was elevated in the highest quintile of total
fat intake. Among women, causes of death other than can-
cer and CVD contributed most to the decreases in HR as-
sociated with increasing fat intake.
In women, the lowest HR for total mortality appeared
at the upper half of the fourth quintile of total fat intake,
at about 23%E. Given the underestimation of the intake
(%E) with the FFQ for the JACC Study (~16%), the lowest
risk might be associated with a higher intake of about
28%E. This falls within the acceptable range recommended
by the Food and Agriculture Organization of the United
Nations (FAO) consultation [1] and the United States
Department of Agriculture (USDA) guideline (20–35%E)
[3], but may exceed the upper limit (25%E) proposed in
dietary reference intakes for Japanese individuals of
30 years or older [2]. If the lowest risk for female total
mortality really is near 28%E of total fat intake, however,
our findings may not be in line with those of Leosdottir
et al. [8]. They did not find any increase in risk among
women who consumed total fat ≥ 35%E compared with
those in the reference group with a mean of 30.8%E.
With regard to cancer, the World Cancer Research
Fund (WCRF) and the American Institute for Cancer
Research (AICR) extensively reviewed the literature and
concluded that there is no convincing or probable evi-
dence for significant effects of dietary fats on any type of
cancer [28]. In the present study, however, the HR for
male cancer mortality was significantly increased by 17%
in the top quintile of total fat intake (Table 2), although
no linear trend was apparent. The elevated risk was pre-
dominantly observed for colorectal cancer; we did not
present this finding in the Results section because de-
tailed analyses by cancer site were outside of the scope
of this study, and the relevant data from the JACC Study
have yet to be published. Nevertheless, the systematic re-
view by the WCRF and AICR [28] mentioned that there
is a limited amount of fairly consistent evidence suggest-
ing that consumption of foods containing animal fats is
a contributing causal factor for colorectal cancer. The
role of dietary fat in the development of colorectal can-
cer may thus help to explain the higher HR for total can-
cer mortality associated with higher intake of total fat.For SFA, the lowest HR in women was found in the high-
est quintile of intake, which would correspond to 7.7%E
considering the overestimation with the FFQ. Although
whether the risk of total mortality rises with further
increase in SFA intake was not clear, this percentage is
consistent with saturated fat intake recommendations by
the FAO consultation (<10%E) and USDA (<10 or 7%E).
The dietary reference intake for Japanese (4.5–7%E) is
lower. Both the FAO consultation and USDA guideline
recommend replacement of excessive SFA with PUFA [1,3].
This recommendation is mainly based on evidence that
replacing dietary SFA with PUFA is associated with a
decreased risk of CHD in both randomized controlled trials
and cohort studies [29]. In contrast, replacing SFA with
carbohydrate or MUFA has been correlated with an
increased risk of CHD in observational cohorts [29]. Never-
theless, our findings regarding P/S ratio did not support the
recommendation; in the present study, the risk for cardio-
vascular death increased at a higher P/S ratio in men.
In a detailed analysis specific to CVD from the JACC
Study [30], SFA intake was inversely associated with
mortality from stroke, but was not correlated with mor-
tality from CHD, again consistent with substitution
models replacing SFA with carbohydrate [30]. The risk
for overall CVD death was decreased with increasing in-
take of SFA in that study. The inverse correlation of SFA
intake with CVD risk was much weaker in the current
study compared with the previous analysis [30]. How-
ever, this may be explicable principally by differences be-
tween the previous and present analyses in terms of the
statistical analyses, including the covariates incorporated
in the models. In particular, we did not include other
fatty acids in the model, while the previous study in-
cluded both n-3 and n-6 PUFA [30]. This is because we
did not intend to adjust for the effects of other fatty acid
intakes correlated with SFA intake in the daily diet.
When we applied a simple age- and sex-adjusted model
as in the similar analysis in the previous study [30],
an inverse association was clearly apparent; HRs for
CVD across quintiles of SFA intake were 1.00, 0.89
(95% CI, 0.81–0.99), 0.91 (0.82–1.00), 0.77 (0.69–0.85),
and 0.74 (0.67–0.83) (trend P < 0.001). This indicates
that the SFA-CVD association was essentially comparable
Table 2 Hazard ratios (HRs) for total, cancer, cardiovascular, and other mortality by quintile (Q1–Q5) of
energy-adjusted fat intake in men: the JACC Study, 1988-2009 (n = 23,115)
No. of deaths HR (95% CI)1 Trend P
Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5
Total fat
Median of intake, %E 10.8 13.9 16.3 18.8 23.3
Total mortality 1,178 1,188 1,238 1,236 1,451 1.00 1.03 (0.95–1.12) 1.02 (0.94–1.10) 0.98 (0.90–1.07) 1.07 (0.98–1.17) 0.31
Cancer mortality 454 505 473 491 564 1.00 1.15 (1.01–1.30) 1.03 (0.90–1.17) 1.05 (0.92–1.21) 1.17 (1.02–1.34) 0.12
Cardiovascular mortality 311 302 339 315 398 1.00 0.98 (0.84–1.16) 1.03 (0.88–1.21) 0.91 (0.77–1.08) 1.05 (0.89–1.24) 0.80
Other mortality 413 381 426 430 489 1.00 0.94 (0.81–1.08) 0.99 (0.86–1.14) 0.95 (0.82–1.09) 0.99 (0.85–1.14) 0.87
SFA
Median of intake, %E 3.0 4.1 4.9 5.8 7.3
Total mortality 1,323 1,246 1,226 1,230 1,266 1.00 0.96 (0.89–1.04) 0.99 (0.91–1.07) 0.96 (0.88–1.04) 0.98 (0.90–1.06) 0.54
Cancer mortality 527 478 469 494 519 1.00 0.93 (0.82–1.06) 0.95 (0.83–1.08) 0.99 (0.87–1.13) 1.05 (0.92–1.20) 0.45
Cardiovascular mortality 343 336 363 302 321 1.00 0.98 (0.84–1.14) 1.13 (0.97–1.31) 0.89 (0.76–1.05) 0.93 (0.79–1.10) 0.30
Other mortality 453 432 394 434 426 1.00 0.97 (0.85–1.11) 0.93 (0.81–1.07) 0.97 (0.85–1.12) 0.93 (0.80–1.07) 0.32
MUFA
Median of intake, %E 3.3 4.3 5.0 5.9 7.4
Total mortality 1,235 1,156 1,226 1,237 1,437 1.00 0.96 (0.88–1.04) 0.98 (0.90–1.07) 0.92 (0.85–1.00) 1.01 (0.93–1.10) 0.99
Cancer mortality 477 469 498 481 562 1.00 1.00 (0.88–1.14) 1.04 (0.91–1.18) 0.96 (0.84–1.10) 1.09 (0.96–1.25) 0.35
Cardiovascular mortality 332 301 315 324 393 1.00 0.92 (0.79–1.08) 0.93 (0.79–1.09) 0.87 (0.74–1.03) 0.99 (0.84–1.17) 0.74
Other mortality 426 386 413 432 482 1.00 0.93 (0.81–1.07) 0.96 (0.83–1.10) 0.92 (0.80–1.06) 0.95 (0.82–1.10) 0.46
PUFA
Median of intake, %E 2.6 3.3 3.7 4.2 5.0
Total mortality 1,012 1,078 1,224 1,374 1,603 1.00 1.03 (0.94–1.12) 1.05 (0.96–1.15) 1.08 (0.98–1.18) 1.08 (0.98–1.18) 0.074
Cancer mortality 425 460 491 531 580 1.00 1.04 (0.91–1.19) 1.03 (0.90–1.19) 1.05 (0.91–1.21) 1.03 (0.89–1.19) 0.66
Cardiovascular mortality 246 261 314 370 474 1.00 1.02 (0.85–1.22) 1.06 (0.89–1.26) 1.10 (0.92–1.31) 1.18 (0.99–1.41) 0.044
Other mortality 341 357 419 473 549 1.00 1.02 (0.87–1.18) 1.06 (0.91–1.23) 1.08 (0.92–1.25) 1.05 (0.89–1.23) 0.47
n-3 PUFA
Median of intake, %E 0.5 0.6 0.8 0.9 1.2
Total mortality 998 1,091 1,252 1,338 1,612 1.00 0.96 (0.88–1.05) 1.01 (0.93–1.11) 1.01 (0.92–1.10) 1.04 (0.95–1.14) 0.21
Cancer mortality 420 434 491 538 604 1.00 0.93 (0.81–1.06) 0.98 (0.85–1.12) 1.01 (0.88–1.16) 1.02 (0.89–1.18) 0.42
Cardiovascular mortality 254 271 315 378 447 1.00 0.91 (0.77–1.09) 0.95 (0.80–1.13) 1.05 (0.89–1.25) 1.02 (0.86–1.21) 0.36
Other mortality 324 386 446 422 561 1.00 1.05 (0.90–1.22) 1.10 (0.95–1.28) 0.96 (0.82–1.12) 1.08 (0.93–1.26) 0.65
n-6 PUFA
Median of intake, %E 2.1 2.7 3.2 3.7 4.5
Total mortality 1,023 1,090 1,236 1,340 1,602 1.00 1.02 (0.94–1.12) 1.08 (0.99–1.18) 1.12 (1.02–1.23) 1.09 (0.99–1.20) 0.022
Cancer mortality 440 472 494 501 580 1.00 1.03 (0.90–1.18) 1.03 (0.90–1.18) 1.02 (0.89–1.18) 1.03 (0.89–1.20) 0.72
Cardiovascular mortality 245 251 326 376 467 1.00 0.96 (0.80–1.15) 1.14 (0.96–1.37) 1.23 (1.03–1.47) 1.18 (0.98–1.42) 0.015
Other mortality 338 367 416 463 555 1.00 1.06 (0.91–1.23) 1.10 (0.94–1.28) 1.15 (0.98–1.35) 1.09 (0.93–1.28) 0.21
PUFA to SFA (P/S) ratio
Median of P/S ratio 0.49 0.64 0.76 0.91 1.17
Total mortality 944 1,206 1,243 1,333 1,565 1.00 1.07 (0.98–1.17) 1.03 (0.94–1.12) 1.09 (1.00–1.19) 1.09 (0.99–1.18) 0.083
Cancer mortality 408 488 486 522 583 1.00 1.05 (0.91–1.20) 0.97 (0.84–1.11) 1.01 (0.88–1.15) 0.99 (0.86–1.13) 0.72
Cardiovascular mortality 192 336 333 358 446 1.00 1.38 (1.15–1.66) 1.29 (1.07–1.55) 1.38 (1.15–1.66) 1.39 (1.16–1.66) 0.011
Other mortality 344 382 424 453 536 1.00 0.92 (0.79–1.07) 0.95 (0.82–1.10) 1.03 (0.89–1.19) 1.02 (0.88–1.18) 0.27
1Adjusted for age, area, education, smoking, alcohol consumption, BMI, sleep duration, walking, consumption of vegetables and fruit, and total energy intake.
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Table 3 Hazard ratios (HRs) for total, cancer, cardiovascular, and other mortality by quintile (Q1–Q5) of energy-adjusted
fat intake in women: the JACC Study, 1988-2009 (n = 35,557)
No. of deaths HR (95% CI)1 Trend P
Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5
Total fat
Median of intake, %E 13.7 17.6 20.1 22.6 26.8
Total mortality 1,284 1,139 1,076 918 948 1.00 1.03 (0.94–1.11) 1.00 (0.92–1.09) 0.88 (0.81–0.96) 0.94 (0.86–1.03) 0.028
Cancer mortality 366 373 364 316 335 1.00 1.07 (0.93–1.25) 1.06 (0.91–1.24) 0.93 (0.79–1.09) 1.01 (0.87–1.19) 0.68
Cardiovascular mortality 430 371 356 278 293 1.00 1.05 (0.91–1.21) 1.07 (0.92–1.24) 0.87 (0.75–1.03) 0.97 (0.83–1.14) 0.34
Other mortality 488 395 356 324 320 1.00 0.97 (0.85–1.11) 0.90 (0.78–1.04) 0.85 (0.73–0.98) 0.87 (0.75–1.01) 0.018
SFA
Median of intake, %E 3.7 5.2 6.3 7.1 8.6
Total mortality 1,426 1,144 1,061 936 798 1.00 0.97 (0.90–1.05) 0.97 (0.90–1.06) 0.91 (0.84–1.00) 0.91 (0.83–1.00) 0.020
Cancer mortality 397 381 336 360 280 1.00 1.06 (0.92–1.22) 0.96 (0.83–1.11) 1.06 (0.92–1.24) 0.92 (0.79–1.09) 0.54
Cardiovascular mortality 484 363 363 264 254 1.00 0.97 (0.84–1.11) 1.07 (0.92–1.23) 0.85 (0.72–0.99) 0.99 (0.84–1.16) 0.46
Other mortality 545 400 362 312 264 1.00 0.91 (0.80–1.04) 0.91 (0.79–1.05) 0.84 (0.73–0.97) 0.84 (0.72–0.98) 0.009
MUFA
Median of intake, %E 4.2 5.4 6.2 7.1 8.6
Total mortality 1,337 1,118 1,038 948 924 1.00 0.98 (0.90–1.06) 0.95 (0.88–1.04) 0.91 (0.83–0.99) 0.91 (0.83–0.99) 0.012
Cancer mortality 374 371 363 320 326 1.00 1.05 (0.91–1.22) 1.06 (0.91–1.23) 0.94 (0.81–1.10) 0.99 (0.84–1.16) 0.56
Cardiovascular mortality 453 359 334 293 289 1.00 0.98 (0.85–1.13) 0.98 (0.84–1.13) 0.92 (0.79–1.08) 0.94 (0.80–1.10) 0.32
Other mortality 510 388 341 335 309 1.00 0.91 (0.80–1.04) 0.84 (0.73–0.97) 0.88 (0.76–1.02) 0.82 (0.70–0.95) 0.006
PUFA
Median of intake, %E 3.2 4.0 4.4 4.8 5.5
Total mortality 1,038 923 1,039 1,144 1,221 1.00 0.91 (0.83–1.00) 0.96 (0.88–1.06) 0.95 (0.87–1.04) 0.88 (0.80–0.97) 0.029
Cancer mortality 343 306 352 380 373 1.00 0.88 (0.75–1.03) 0.95 (0.81–1.11) 0.95 (0.81–1.12) 0.86 (0.72–1.01) 0.17
Cardiovascular mortality 329 283 344 363 409 1.00 0.90 (0.77–1.06) 1.03 (0.87–1.21) 0.96 (0.81–1.13) 0.93 (0.79–1.10) 0.59
Other mortality 366 334 343 401 439 1.00 0.95 (0.82–1.11) 0.91 (0.78–1.07) 0.93 (0.80–1.09) 0.85 (0.73–1.00) 0.061
n-3 PUFA
Median of intake, %E 0.6 0.8 0.9 1.1 1.3
Total mortality 943 973 1,088 1,075 1,276 1.00 0.95 (0.87–1.04) 0.95 (0.87–1.05) 0.91 (0.83–1.00) 0.92 (0.84–1.01) 0.053
Cancer mortality 317 333 351 363 388 1.00 0.97 (0.83–1.13) 0.93 (0.79–1.09) 0.91 (0.77–1.07) 0.88 (0.74–1.04) 0.092
Cardiovascular mortality 298 296 388 337 408 1.00 0.90 (0.77–1.07) 1.06 (0.91–1.24) 0.91 (0.77–1.07) 0.92 (0.78–1.09) 0.36
Other mortality 328 344 349 375 480 1.00 0.96 (0.82–1.12) 0.87 (0.74–1.01) 0.89 (0.76–1.05) 0.95 (0.81–1.11) 0.42
n-6 PUFA
Median of intake, %E 2.6 3.3 3.8 4.3 5.0
Total mortality 1,003 922 1,000 1,181 1,249 1.00 0.94 (0.86–1.03) 1.00 (0.91–1.10) 1.00 (0.91–1.10) 0.89 (0.81–0.98) 0.065
Cancer mortality 328 324 342 390 368 1.00 0.98 (0.84–1.15) 1.01 (0.86–1.19) 1.05 (0.89–1.23) 0.89 (0.75–1.05) 0.33
Cardiovascular mortality 312 281 314 391 429 1.00 0.93 (0.79–1.10) 1.02 (0.86–1.21) 1.04 (0.88–1.23) 0.95 (0.81–1.13) 0.92
Other mortality 363 317 344 400 452 1.00 0.89 (0.76–1.04) 0.95 (0.81–1.11) 0.91 (0.78–1.06) 0.83 (0.71–0.97) 0.032
PUFA to SFA (P/S) ratio
Median of P/S ratio 0.48 0.61 0.71 0.85 1.12
Total mortality 736 860 1,070 1,170 1,529 1.00 0.97 (0.88–1.08) 1.01 (0.92–1.12) 1.03 (0.93–1.13) 1.02 (0.93–1.12) 0.40
Cancer mortality 286 303 340 421 404 1.00 0.90 (0.77–1.07) 0.90 (0.76–1.06) 1.08 (0.92–1.26) 0.88 (0.75–1.04) 0.49
Cardiovascular mortality 207 270 367 342 542 1.00 1.07 (0.89–1.28) 1.17 (0.98–1.40) 0.99 (0.83–1.19) 1.12 (0.94–1.32) 0.48
Other mortality 243 287 363 407 583 1.00 0.98 (0.82–1.16) 1.01 (0.85–1.20) 1.03 (0.87–1.21) 1.08 (0.92–1.26) 0.19
1Adjusted for age, area, education, smoking, alcohol consumption, BMI, sleep duration, walking, consumption of vegetables and fruit, and total energy intake.
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http://www.nutritionandmetabolism.com/content/11/1/12between the present and previous analyses. SFA intake
tended to be associated, although not significantly, with a
decreased risk of stroke in a meta-analysis of cohort
studies [31]. Regarding the role of SFA in relation to
all-cause mortality when used to replace macronutrients,
Nagata et al. showed an association between high SFA
intake and higher total mortality among women in a
model substituting SFA for carbohydrates [9].
In women, the inverse association between SFA intake
and mortality was most evident for those causes of death
other than cancer and CVD. Those causes mainly com-
prised injury (ICD-10: S00-T98) and pneumonia (ICD-10:
J12-J18), accounting for 19.4% and 15.9% of all other causes
of female deaths (n = 1,883), respectively. Low serum
cholesterol levels have been associated with external-cause
mortality such as suicide and accidents in prospective
studies [32-34]. Such results may support the current
findings, because the increased SFA intake raises serum
cholesterol levels [29] and therefore might decrease the risk
of external-cause mortality. In Japan, suicide and accidents
accounted for almost all external causes of death (injury
deaths), at 53.3% and 41.7%, respectively, in 1999, as the
midpoint of the follow-up period for the present study
[35]. In addition to external causes of death, community-
acquired pneumonia has been associated with low serum
cholesterol in high-risk populations [36]. Fat insufficiency
may disturb the absorption of fat-soluble vitamins includ-
ing vitamins A and E [1-3], which are required to maintain
resistance to infectious diseases [37].
Only a few studies have directly correlated MUFA intake
with all-cause mortality. In the Italian Longitudinal Study
on Aging, higher MUFA intake was associated with
decreased total mortality (HR for one standard deviation
(SD) increment, 0.81; 95% CI, 0.66–0.99) [38], which may
corroborate the inverse association among women in the
current study. Alternatively, the Mediterranean diet has
often been associated with decreased risk of all-cause death,
cancer, and CVD [39]. This may support our finding be-
cause the Mediterranean diet is rich in MUFA. However,
other dietary factors in the Mediterranean diet, such as
vegetables and fruit, have to be considered [39]. Since
dietary MUFA intake was very strongly correlated with SFA
intake, examining the effect of dietary MUFA independ-
ently of SFA using multivariate models was difficult; the
correlation coefficient for energy-adjusted intake was 0.86
in men and 0.85 in women in the analytic cohort.
PUFA intake correlated negatively with total mortality
in women, which appeared to be due to a decreased risk
of cancer death associated with a higher intake of n-3
PUFA and a decreased risk of death from other causes
associated with a higher intake of n-6 PUFA. Marine n-3
PUFA was associated with a lower risk of breast cancer in
a meta-analysis of cohort studies [40]. Although no
protective effect of n-3 fats against cancer was shown in asystematic review [41], typical fish intake is much higher in
Asian populations, including Japanese, than in Western
populations [40]. One possibility, therefore, is that prevent-
ive effects of n-3 PUFA are suggested in studies from
Japan. One study related linoleic acid intake to a lower risk
of community-acquired pneumonia [42], which may partly
explain the association between decreased risk of death
from other causes and higher intake of n-6 PUFA.
We did not expect the elevated risk of male cardiovascu-
lar mortality associated with higher intake of n-6 PUFA, as
several studies have shown inverse associations between
n-6 PUFA intake and CVD [43]. This finding could repre-
sent a chance phenomenon, since it was not observed in
women. The role of dietary n-6 PUFA in the development
of CVD, however, remains controversial [44,45], and this
study may provide additional data for discussion. Of note,
the increased risk of male CVD death was principally due
to stroke instead of CHD. Further investigations may
therefore need to focus on stroke.
The JACC Study previously reported an inverse associ-
ation between n-3 PUFA intake and CVD mortality [46]
that was not clear in the current analysis. As mentioned
in the discussion on SFA and CVD, this apparent incon-
sistency may be attributable to differences between the
previous and current analyses in terms of the covariates
included in multivariate models, especially dietary intakes
of SFA and n-6 PUFA. When age- and sex-adjusted HRs
were estimated as in the preceding study [46], we found
an inverse (though not strong) association similar to that
in the previous study; HRs for CVD across quintiles of n-3
PUFA intake were 1.00, 0.89 (95% CI, 0.80–1.00), 0.97
(0.87–1.09), 0.98 (0.88–1.09), and 0.89 (0.80–1.00) (trend
P = 0.21). Regarding investigations on fat and cancer in the
JACC Study, the higher serum level of n-3 PUFA was as-
sociated with decreased risk of male colorectal cancer [47]
and higher dietary intakes of fish fat and long-chain n-3
fatty acids were correlated with a reduced risk of female
breast cancer [48]. Those studies, however, cannot be dir-
ectly compared with our own because of the large differ-
ence in exposure assessment; they used serum fatty acids
or specific fat/fatty acids (e.g., fish fat, long-chain n-3 fatty
acids) instead of dietary total n-3 PUFA. Furthermore,
those studies defined incidence of cancer as endpoints,
while we adopted cancer deaths.
In Europe and the United States, high fat intake is as-
sociated with unhealthy living and unfavorable social
class, represented as low intakes of fruit, vegetables and
fiber, and increased smoking and alcohol intake on a
population level [49]. Conversely, a higher fat intake was
associated with higher education, less smoking and male
alcohol consumption, and higher consumption of fruit
and vegetables in the current study (Table 1). One study
based on nationwide surveys in Japan reported an in-


































Figure 1 Hazard ratios (HRs) for total mortality according to total fat intake by sex. HRs within the first to third quintiles and the lower and
upper halves of the fourth and top quintiles of total fat intake (%E) are shown for men (A; n = 23,115) and women (B; n = 35,557). The reference
group comprised participants with the lowest quintile of fat intake (%E). HRs were adjusted for age, area, education, smoking, alcohol consumption,
BMI, sleep duration, walking, consumption of vegetables and fruit, and total energy intake. HRs with 95% confidence intervals (shown as error bars) are
plotted against median intake of fat (%E) in each category. The 95% confidence intervals for the second to third quintiles and lower and upper halves
of the fourth and top quintiles of intake (%E), from lowest through to highest intake, were 0.95–1.12, 0.93–1.10, 0.94–1.15, 0.83–1.02, 0.98–1.20, and
0.96–1.17 for men, and 0.94–1.11, 0.92–1.09, 0.81–1.01, 0.77–0.96, 0.80-1.00, and 0.89–1.12 for women, respectively.
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penditure also correlated positively with vitamin C and
fiber intakes in that study. This suggests that individuals
in a higher socioeconomic status in Japan consume not
only more foods considered good for health (e.g., vegeta-
bles and fruit), but also more fat-rich foods, as seen in
our study. Similar correlations between nutrient intakes
and income or educational level have also been observed
in Chinese women [51].
We therefore considered background characteristics
and lifestyle factors including consumption of vegetables
and fruit in participants as much as possible from the
available data in our statistical analyses. Residual con-
founding, however, might have affected the results, and
the differences in findings regarding fat and mortality
among various populations may be partly attributable to
differences in characteristics related to fat intake among
populations.
No associations between fat intake and total mortality
were apparent in men. This is inconsistent with findings
from the Takayama Study among Japanese, which showed
an inverse correlation with risk of all-cause mortality for
total fat only in men [9]. For comparison, we tried to fur-
ther adjust for protein intake as performed in that study
[9], but no significant correlation appeared in men.
The difference in alcohol consumption between sexes
may be relevant at least in our cohort, and possibly
among Japanese in general. Alcohol consumption con-
tributes to energy intake and therefore decreases the
percent of energy derived from fat, even if fat intake re-
mains the same. Percentages of non-alcohol energy werenot applied in the present study because dietary guide-
lines do not explicitly exclude alcohol energy from the
denominator [1-3]. In the current cohort, women con-
sumed only 1.7 g (12 kcal) per day of alcohol on average,
whereas men drank 25.4 g (180 kcal) per day. We did
not identify significant trends between fat intake and
total mortality in men, even in the analysis limited to
never-drinkers. Sex differences in our population are
thus not well explained and should be examined in fur-
ther investigations.
A tendency toward a somewhat reduced risk, however,
was observed in the second highest quintile of total fat
intake (HR, 0.92) among male never-drinkers, although
this was not significant, partly due to the rather small
sample size (n = 4,454). Larger studies of non-drinkers
may also be warranted to evaluate effect modification or
possible residual confounding by alcohol intake.
Similar sex differences were also found for SFA,
MUFA, and PUFA in the present study; risk of total
mortality was decreased with increasing intakes of SFA,
MUFA and PUFA in women, whereas the risk was
somewhat elevated with increasing PUFA intake in men.
These findings, however, are not in line with preceding
studies. Leosdottir et al. [8] reported a positive correl-
ation between MUFA intake and total mortality, particu-
larly in men, while Nagata et al. [9] found an inverse
correlation of PUFA and a positive correlation of SFA
with all-cause mortality in men and women, respectively.
Further investigations are required before any conclu-
sions can be drawn regarding differences in the effects
of fatty-acid groups by sex.
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spective design, large sample size, long follow-up, and
multivariate adjustments for potential confounding fac-
tors. The design enabled us to define death as an end-
point, and more than 11,000 events made detailed
analysis possible. Moreover, the relatively lower level of
fat intake among samples provided a unique opportunity
to examine associations of fat intake with total mortality.
Some methodological limitations to our study warrant
discussion. First, we used a simple FFQ with only 40 food
items. Total energy intake may thus have been underesti-
mated because of the foods not covered by the FFQ. How-
ever, the FFQ was validated by referring to dietary records,
and the over- or underestimation of intakes (%E) of total
fat and its components were adjusted using information
from the validation study. We could not estimate the in-
take of trans-fatty acids with this FFQ. Although the mean
intake in Japan [52,53] is reported to be lower than the
proposed upper limit (1% of total energy) [1], some Japa-
nese, particularly women, might have a higher intake of
trans-fatty acids [53]. Second, we excluded substantial
numbers of participants (n = 22,941) because of insuffi-
cient dietary information. The omitted participants were
older and more likely to be men compared with those
included in the analysis (mean age ± SD, 60.9 ± 9.8 vs.
56.1 ± 9.9 years; men, 45.7% vs. 39.4%). Other background
characteristics, however, were quite similar between the 2
groups of participants, suggesting that these exclusions
did not lead to any major selection bias. Third, fat intakes
were assessed only once, at baseline. Fourth, the self-
reporting of body weight and energy/nutrient intake might
have led to bias. Underreporting of energy intake has been
reported as more pronounced among women, overweight
subjects and those with higher fat intake in European
populations [54]. In Asian populations, two studies
reported that overweight or obese men and women
(BMI ≥25 kg/m2) tended to underestimate their weight
and/or BMI [55,56]. Finally, because the present study was
conducted among Japanese and the health effects of diet-
ary fat may vary among populations with different genetic
backgrounds [57], extrapolation to other populations must
be made with caution.
Conclusions
A U-shaped association was found between total fat in-
take and all-cause mortality in women. The risk for fe-
male mortality decreased with increasing intakes of SFA,
MUFA, and PUFA through the top quintile of intakes.
Our findings from a large cohort study among popula-
tions with relatively low fat intake will provide evidence
regarding optimal levels of fat intake.Competing interests
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